GALNT14 anticorps (AA 101-200)
-
- Antigène Voir toutes GALNT14 Anticorps
- GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))
-
Épitope
- AA 101-200
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GALNT14 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
- Réactivité croisée
- Humain
- Homologie
- Mouse,Rat
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human GALNT14
- Isotype
- IgG
- Top Product
- Discover our top product GALNT14 Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer." dans: Biomedicine & pharmacotherapy, Vol. 84, pp. 1078-1087, (2016) (PubMed).
: "
-
Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer." dans: Biomedicine & pharmacotherapy, Vol. 84, pp. 1078-1087, (2016) (PubMed).
-
- Antigène
- GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))
- Autre désignation
- GALNT14 (GALNT14 Produits)
- Synonymes
- anticorps 0610033M06Rik, anticorps si:ch211-147c1.1, anticorps GALNT15, anticorps GalNac-T10, anticorps GalNac-T14, anticorps polypeptide N-acetylgalactosaminyltransferase 14, anticorps UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14), anticorps GALNT14, anticorps galnt14, anticorps Galnt14
- Sujet
-
Synonyms: GalNAc T14, GalNAc-T14, Galnt14, GALNT14, GalNac-T10, GALNT15, pp-GaNTase 14, GLT14_HUMAN, Polypeptide GalNAc transferase 14, Polypeptide N acetylgalactosaminyltransferase 14, Polypeptide N-acetylgalactosaminyltransferase 14, pp GaNTase 14, Protein UDP acetylgalactosaminyltransferase 14, Protein-UDP acetylgalactosaminyltransferase 14, UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 14, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14.
Background: This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
-